Brain

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and Handsome Albert Einstein MIAMI, March…

19 hours ago

Gain Therapeutics to Present at Public Ventures Discovery Day

Gain Therapeutics’ Former CEO and current Board Member Eric Richman to participate in fireside chat hosted by Public Ventures President…

19 hours ago

Ibogaine By David Dardashti: Government Urged to Increase Funding for Quantum Electrodynamics Research

Exploring the Relationship Between Glial Cells and Electromagnetic Waves David Dardashti and Quantum Electrodynamic Ibogaine By David Dardashti supports quantum…

19 hours ago

Glioblastoma Foundation to Be Official Charity Partner of the 2024 Los Angeles Marathon

DURHAM, NC / ACCESSWIRE / March 14, 2024 / The Glioblastoma Foundation is proud to be a charity partner for…

3 days ago

AlzeCure to Partake in Redeye Theme: Alzheimer on March 21

STOCKHOLM, SWEDEN / ACCESSWIRE / March 14, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

3 days ago

Hop On A Cure Announces Philanthropic Commitment to Houston Methodist to Support ALS Research

ATLANTA, GA / ACCESSWIRE / March 13, 2024 / A leading advocate in the fight against ALS, Hop On A…

4 days ago

NovaSight Announces Publication of CureSight(TM)’s Pivotal Study of One-Year Follow-Up Outcomes

Study Demonstrates That Patients Achieved Long-Term Visual Acuity Gains Following CureSight TreatmentAIRPORT CITY, ISRAEL / ACCESSWIRE / March 13, 2024…

4 days ago

Cerevance Announces Presentation at Alzheimer’s Research UK Conference

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system…

4 days ago

Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”

Event hosted by the U.S. Army Medical Research and Development Command’s (USAMRDC) Combat Casualty Care Research Program (CCCRP) Neurotrauma Portfolio…

4 days ago

Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights

Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8® for the treatment of ALS with the objective of submitting…

4 days ago